×
About 1,373 results

ALLMedicine™ Hypernatremia Center

Research & Reviews  464 results

Higher parenteral electrolyte intakes in preterm infants during first week of life: Eff...
https://doi.org/10.1097/MPG.0000000000003532
Journal of Pediatric Gastroenterology and Nutrition; Späth C, Sjöström ES et. al.

Jun 22nd, 2022 - This study aimed to investigate the effects of a higher intake of electrolytes from parenteral nutrition (PN) on plasma electrolyte concentrations in very low birth weight (VLBW, <1500 g) infants. This was a single-centre cohort study including al...

Diuretic Treatment in Acute Heart Failure With Volume Overload Guided by Serial Spot Urine Sodium Assessment
https://clinicaltrials.gov/ct2/show/NCT05411991

Jun 15th, 2022 - Key interventions are: Assessment of UNa in spot urine samples after every bolus administration of loop diuretics with continuation of intravenous diuretics until resolution of clinical signs of fluid overload AND UNa <80 mmol/L Dosing of loop diu...

Clinical features and imaging manifestations of acute necrotizing encephalopathy in chi...
https://doi.org/10.1002/jdn.10201
International Journal of Developmental Neuroscience : The... Wu L, Peng H et. al.

Jun 11th, 2022 - We summarized the clinical features of acute necrotizing encephalopathy (ANE) in children. Clinical data of 14 children with ANE at one center from January 2017 to January 2020 were retrospectively analyzed. ANE severity score (ANE-ss) was used to...

Hematocrit
https://emedicine.medscape.com/article/2054320-print

May 31st, 2022 - The reference range varies depending on the methodology used. Normal ranges should be validated by individual clinical laboratories. Reference ranges (SI units/conventional units) are as follows: Males - 0.40-0.54/40-54% Females - 0.36-0.46/36-46%...

Prognostic value of dysnatremia for survival in neuroendocrine neoplasm patients.
https://doi.org/10.1530/EJE-22-0023
European Journal of Endocrinology; Refardt J, Brabander T et. al.

May 14th, 2022 - Hyponatremia and hypernatremia are common electrolyte abnormalities in patients with malignancy and have been independently associated with worse survival outcomes. To date, there are no data on the impact of dysnatremia on survival outcomes in pa...

see more →

Drugs  8 results see all →

Clinicaltrials.gov  43 results

Diuretic Treatment in Acute Heart Failure With Volume Overload Guided by Serial Spot Urine Sodium Assessment
https://clinicaltrials.gov/ct2/show/NCT05411991

Jun 15th, 2022 - Key interventions are: Assessment of UNa in spot urine samples after every bolus administration of loop diuretics with continuation of intravenous diuretics until resolution of clinical signs of fluid overload AND UNa <80 mmol/L Dosing of loop diu...

Hyponatremia Study (Delayed Hyponatremia After Pituitary Surgery)
https://clinicaltrials.gov/ct2/show/NCT03636568

Apr 12th, 2022 - Any adult patient with a pituitary adenoma (either non-functioning, prolactin-secreting, growth hormone secreting, gonadotropin secreting, or TSH (thyroid stimulating hormone) secreting) or cyst scheduled to undergo transsphenoidal resection will ...

Effect of Dexmedetomidine on the Minimum Alveolar Concentration of Sevoflurane
https://clinicaltrials.gov/ct2/show/NCT03384563

Apr 6th, 2022 - The anesthetic potency of an inhalational anesthetic is measured by the minimum alveolar concentration (MAC), or the dose required to suppress movement to a surgical stimulus in 50% of patients. This measure of potency may also be used to assess t...

Efficacy and Safety of Rapid Intermittent Correction Compared With Slow Continuous Correction in Patients With Severe Hypernatremia
https://clinicaltrials.gov/ct2/show/NCT04949139

Feb 21st, 2022 - Hypernatremia is defined as serum sodium (sNa) levels above 145 mmol/L and is caused by abnormalities in water balance, mainly in children, elderly, and critically ill patients. It occurs in 3% of hospitalized patients and in 9% of critically ill ...

Safety and Efficacy of Early Administration of Dexamethasone in High-risk Sepsis
https://clinicaltrials.gov/ct2/show/NCT05136560

Jan 25th, 2022 - The septic adult patients of high risk would be enrolled in 2 emergency departments. Sepsis would be defined by Sepsis-3 definition. High risk is defined as initial systolic blood pressure less than 90 mmHg or blood lactate level over 2 mmol/L. Th...

see more →

News  34 results

Top strategies for preventing tardive dyskinesia
https://www.mdedge.com/psychiatry/article/251979/movement-disorders/top-strategies-preventing-tardive-dyskinesia
Doug Brunk

Feb 18th, 2022 - LAS VEGAS – In the opinion of Christoph U. Correll, MD, tardive dyskinesia (TD) “has been somewhat forgotten” by psychiatrists because the risk of patients developing the condition is considered to be significantly lower with second-generation ant.

Bempegaldesleukin/Nivolumab Combo Upholds Durable Benefit in Metastatic Melanoma
https://www.onclive.com/view/bempegaldesleukin-nivolumab-combo-upholds-durable-benefit-in-metastatic-melanoma

Oct 6th, 2021 - November 13, 2020 - The combination of bempegaldesleukin (NKTR-214) and the PD-1 inhibitor nivolumab (Opdivo) elicited a confirmed best overall response rate (ORR) of 53% in efficacy-evaluable patients with metastatic melanoma, according to update...

Inpatient Sodium Imbalances Linked to Adverse COVID-19 Outcomes
https://www.medscape.com/viewarticle/947165

Mar 10th, 2021 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. Both high and low serum sodium levels are associated with adverse outcomes for hospitalized patients with COVID-19, new research suggests. In the ...

Isotonic Fluids Without Potassium Could Be Harmful for Some Acutely Ill Kids
https://www.medscape.com/viewarticle/939875

Oct 28th, 2020 - NEW YORK (Reuters Health) - A recent move to use isotonic rather than hypotonic intravenous fluids (IVFs) in acutely ill children could be boosting their risk of developing electrolyte disorders, a new trial suggests. "Commercially available isoto...

AUTO3 CAR T-Cell Product Plus Pembrolizumab Shows Clinical Activity, Tolerability in Relapsed/Refractory DLBCL
https://www.onclive.com/view/auto3-car-t-cell-product-plus-pembrolizumab-shows-clinical-activity-tolerability-in-relapsed-refractory-dlbcl

Sep 23rd, 2020 - The investigational CAR T-cell product AUTO3 in combination with pembrolizumab (Keytruda) was found to have a tolerable safety profile and elicit durable complete responses (CRs) in patients with relapsed/refractory diffuse large B-cell lymphoma (...

see more →